A switch in the brain of people with epilepsy dictates whether their seizures will be relatively mild or lead to a dangerous and debilitating loss of consciousness, Yale researchers have found.The study published April 11 in the journal Neurology showed...
Yale’s Craig Crews leveraged basic science research that formed the basis of a cancer drug eventually valued at nearly $10 billion.Now Crews, the Lewis B. Cullman Professor of Molecular, Cellular and Developmental Biology and professor of chemistry and...
